Premium
Burden of serious fungal infections in Nepal
Author(s) -
Khwakhali Ushana Shrestha,
Denning David W.
Publication year - 2015
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/myc.12393
Subject(s) - allergic bronchopulmonary aspergillosis , incidence (geometry) , fungal keratitis , aspergillosis , medicine , epidemiology , asthma , pneumonia , population , pneumocystis pneumonia , tuberculosis , mycosis , aspergillus , immunology , environmental health , dermatology , biology , pathology , keratitis , pneumocystis jirovecii , microbiology and biotechnology , immunoglobulin e , physics , antibody , optics
Summary There are few reports of serious fungal infections in Nepal though the pathogenic and allergenic fungi including Aspergillus species are common in the atmosphere. Herein, we estimate the burden of serious fungal infections in Nepal. All published papers reporting fungal infection rates from Nepal were identified. When few data existed, we used specific populations at risk and fungal infection frequencies in those populations to estimate national incidence or prevalence. Of the 27.3 M population, about 1.87% was estimated to suffer from serious fungal infections annually. We estimated the incidence of fungal keratitis at 73 per 100 000 annually. Chronic obstructive pulmonary disease is common with 215 765 cases, contributing to 1119 cases of invasive aspergillosis annually. Of 381 822 adult asthma cases, we estimated 9546 patients (range 2673–13 364) develop allergic bronchopulmonary aspergillosis and 12 600 have severe asthma with fungal sensitisation. Based on 26 219 cases of pulmonary tuberculosis, the annual incidence of new chronic pulmonary aspergillosis ( CPA ) cases was estimated at 1678 with a 5 year period prevalence of 5289, 80% of CPA cases. Of 22 994 HIV patients with CD 4 counts <350 not on antiretrovirals, Pneumocystis pneumonia was estimated at 990 cases annually. Cases of oral and oesophageal candidiasis in HIV / AIDS patients were estimated at 10 347 and 2950, respectively. There is a significant burden of serious fungal infections in Nepal. Epidemiological studies are necessary to validate these estimates.